Bill

Bill > HR1857


US HR1857

US HR1857
Protecting Access to Safe and Effective Medicines Act of 2021


summary

Introduced
03/11/2021
In Committee
03/12/2021
Crossed Over
Passed
Dead
01/03/2023

Introduced Session

117th Congress

Bill Summary

A BILL To amend the Federal Food, Drug, and Cosmetic Act to clarify the meaning of a new chemical entity.

AI Summary

This bill amends the Federal Food, Drug, and Cosmetic Act to clarify the meaning of a "new chemical entity" by replacing references to "active ingredient" with "active moiety" throughout the Act. The "active moiety" is defined by the Secretary of Health and Human Services in the Code of Federal Regulations. This change affects various sections of the Act, including provisions related to exclusivity periods for new drugs, approvals of animal drugs, and incentives for rare disease treatments. The purpose of this bill is to provide clarity and update the language used in the Act to better reflect the current scientific understanding of drug composition and development.

Committee Categories

Business and Industry, Health and Social Services

Sponsors (2)

Last Action

Referred to the Subcommittee on Health. (on 03/12/2021)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...